Picard Medical, Inc.
Datakwaliteit: 100%
PMI
NYSE
Manufacturing
Measuring & Analyzing Instruments
€ 1,01
▼
€ 0,01
(-0,98%)
Marktkapitalisatie: 75,93 M
Prijs
€ 1,01
Marktkapitalisatie
75,93 M
Dagbereik
€ 1,00 — € 1,05
52-Weeksbereik
€ 0,92 — € 13,68
Volume
35.218
Openen € 1,03
50D / 200D Gem.
€ 1,34
24,34% below
50D / 200D Gem.
€ 3,65
72,33% below
Quick Summary
Belangrijkste Punten
Negative free cash flow of -15,67 M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
N/A
ROICN/A
Net Margin-546,60%
Op. Margin-268,36%
Veiligheid
Debt / Equity
N/A
Current Ratio2,16
Interest CoverageN/A
Waardering
PE (TTM)
-2,81
Onder sectorgemiddelde (-1,48)
P/B Ratio9,53
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -2,8 | -1,5 |
| P/B | 9,5 | 1,6 |
| ROE % | — | -53,4 |
| Net Margin % | -546,6 | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 4,94 M | Net Income (TTM) | -27,00 M |
| ROE | N/A | ROA | -214,10% |
| Gross Margin | -4,13% | Operating Margin | -268,36% |
| Net Margin | -546,60% | Free Cash Flow (TTM) | -15,67 M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2,16 |
| Interest Coverage | N/A | Asset Turnover | 0,39 |
| Working Capital | 6,22 M | Tangible Book Value | 6,82 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -2,81 | Forward P/E | N/A |
| P/B Ratio | 9,53 | P/S Ratio | 15,37 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -20,64% | ||
| Market Cap | 75,93 M | Enterprise Value | 73,12 M |
| Per Share | |||
| EPS (Diluted TTM) | N/A | Revenue / Share | 0,07 |
| FCF / Share | -0,21 | OCF / Share | -0,21 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 58,04% |
| SBC-Adj. FCF | -16,43 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 |
|---|---|
| Revenue | 4,94 M |
| Net Income | -27,00 M |
| EPS (Diluted) | — |
| Gross Profit | -204.000,0 |
| Operating Income | -13,26 M |
| EBITDA | — |
| R&D Expenses | 3,05 M |
| SG&A Expenses | 10,00 M |
| D&A | 163.000,0 |
| Interest Expense | — |
| Income Tax | 35.000,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 |
|---|---|
| Total Assets | 22,55 M |
| Total Liabilities | 18,76 M |
| Shareholders' Equity | 3,79 M |
| Total Debt | — |
| Cash & Equivalents | 7,45 M |
| Current Assets | 20,73 M |
| Current Liabilities | 18,70 M |
{"event":"ticker_viewed","properties":{"ticker":"PMI","listing_kind":"stock","pathname":"/stocks/pmi","exchange":"NYSE","country":"US"}}